Scientists Set Five Grand Challenges for Nanotechnology Risk Research
Thursday November 16, 2006 • 9-10 AM
Woodrow Wilson International Center for Scholars, 5th Floor Conference Room
WASHINGTON, D.C.—Fourteen top international scientists in the field of nanotechnology have identified Five Grand Challenges for nanotechnology risk research that must be met if the technology is to reach its full potential. Their findings are the subject of a major paper published in the November 16 issue of the journal Nature.
The paper’s lead author is Project on Emerging Nanotechnologies Chief Science Advisor Andrew Maynard. Co-authors (see below) are among the world’s foremost nanotechnology risk and applications researchers from universities, government, and industry in the United States and Europe.
Three of the paper’s authors—Dr. Maynard, Dr. Martin A. Philbert of the University of Michigan School of Public Health, and Dr. Sally Tinkle of the National Institute of Environmental Health Sciences—will discuss their recommendations at a program and live webcast on Thursday, November 16th at 9:00 a.m. in the 5th Floor Conference Room of the Woodrow Wilson Center.
Dr. Andrew Maynard, Chief Science Advisor, Project on Emerging Nanotechnologies, Woodrow Wilson Center. Dr. Maynard formerly served at the National Institute of Occupational Safety and Health (NIOSH), part of the U.S. Centers for Disease Control and Prevention (CDC), where he was instrumental in developing NIOSH’s nanotechnology research program. He also was a member of the U.S. government’s Nanoscale Science, Engineering and Technology (NSET) subcommittee of the National Science and Technology Council, and co-chaired the Nanotechnology Health and Environmental Implications (NEHI) working group of NSET. Presentation
Dr. Martin A. Philbert, Professor of Toxicology and Senior Associate Dean for Research, University of Michigan School of Public Health. Dr. Philbert’s research includes the development of nanotechnology for intracellular measurement of biochemicals and ions, and for the early detection of brain tumors.
Dr. Sally S. Tinkle, Assistant to the Deputy Director, National Institute of Environmental Health Sciences, National Institutes of Health. Dr. Tinkle developed the NIEHS extramural nanotoxicology portfolio, chairs the NIH Nano Task Force Health Implications working group, and participates in the NSET and NEHI.
David Rejeski, Director, Project on Emerging Nanotechnologies
November 16, 2006